Group items tagged

Analysis of leukemia business development enables tracking cutting edge companies, therapies and new technologies. Analysis of key areas of pharmaceutical R&D helps identify emerging leukemia products. The tool is designed in a way to assist in finding right partners, optimizing licensing deals and choosing projects that give the best competitive advantage.

An extensive research of the primary battery and cell markets in the world along with insights into the market size for primary batteries and cells indicate strong growth potentials and assists marketers in formulating strategic business decisions. Major product segments include air-zinc primary batteries and cells, lithium primary batteries and cells, manganese dioxide primary batteries and cells, mercuric oxide primary batteries and cells, silver oxide primary batteries and cells, parts of primary batteries and cells.

An analysis of defense business along with industry sentiments globally on the latest economic and customer issues, and their impact on investment decisions reveal growth prospects within the defense industry. Change in supplier prices of various products, are likely to influence the growth prospects of the defence industry over the next six months. Economic conditions are expected to be more favorable in Africa and Australasia in Q1 2014 compared to Q4 2013. A decrease in buyers' confidence and uneven market conditions in North America remain key concerns for executives operating in Asia-Pacific region.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Global Markets Directs, Dengue - Pipeline Review, H1 2014, provides an overview of the Dengues therapeutic pipeline. It also enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.